Abstract:Background: The decreased osteogenic differentiation ability of mesenchymal stem cells (MSCs) is one of the important reasons for SOP. Inhibition of Wnt signaling in MSCs is closely related to SOP. Microtubule actin crosslinking factor 1 (MACF1) is an important regulator in Wnt/β-catenin signal transduction. However, whether the specific expression of MACF1 in MSC regulates SOP and its mechanism remains unclear. Methods: We established MSC-specific Prrx1 (Prx1) promoter-driven MACF1 conditional knock-in (MACF-KI) mice, naturally aged male mice, and ovariectomized female mice models. Micro-CT, H&E staining, double calcein labeling, and the three-point bending test were used to explore the effects of MACF1 on bone formation and bone microstructure in the SOP mice model. Bioinformatics analysis, ChIP-PCR, qPCR, and ALP staining were used to explore the effects and mechanisms of MACF1 on MSCs' osteogenic differentiation. Results: Microarray analysis revealed that the expression of MACF1 and positive regulators of the Wnt pathway (such as TCF4, β-catenin, Dvl) was decreased in human MSCs (hMSCs) isolated from aged osteoporotic than non-osteoporotic patients. The ALP activity and osteogenesis marker genes (Alp, Runx2, and Bglap) expression in mouse MSCs was downregulated during aging. Furthermore, Micro-CT analysis of the femur from 2-month-old MSC-specific Prrx1 (Prx1) promoter-driven MACF1 conditional knock-in (MACF-cKI) mice showed no significant trabecular bone changes compared to wild-type littermate controls, whereas 18- and 21-month-old MACF1 c-KI animals displayed increased bone mineral densities (BMD), improved bone microstructure, and increased maximum compression stress. In addition, the ovariectomy (OVX)-induced osteoporosis model of MACF1 c-KI mice had significantly higher trabecular volume and number, and increased bone formation rate than that in control mice. Mechanistically, ChIP-PCR showed that TCF4 could bind to the promoter region of the host gene miR-335-5p. Moreover, MACF1 could regulate the expression of miR-335-5p by TCF4 during the osteogenic differentiation of MSCs. Conclusion: These data indicate that MACF1 positively regulates MSCs osteogenesis and bone formation through the TCF4/miR-335-5p signaling pathway in SOP, suggesting that targeting MACF1 may be a novel therapeutic approach against SOP. The translational potential of this article: MACF1, an important switch in the Wnt signaling pathway, can alleviate SOP through the TCF4/miR-335-5p signaling pathway in mice model. It might act as a therapeutic target for the treatment of SOP to improve bone function.

MACF1 alleviates aging-related osteoporosis via HES1

MiR-138-5p Targets MACF1 to Aggravate Aging-related Bone Loss

MACF1 Facilitates SMAD7 Nuclear Translocation to Drive Bone Formation in Mice

Mesenchymal MACF1 Facilitates SMAD7 Nuclear Translocation to Drive Bone Formation

MACF1 overexpression in BMSCs alleviates senile osteoporosis in mice through TCF4/miR-335-5p signaling pathway

MACF1 Overexpression by Transfecting the 21 Kbp Large Plasmid PEGFP-C1A-ACF7 Promotes Osteoblast Differentiation and Bone Formation.

MACF1 Promotes Osteoblastic Cell Migration by Regulating MAP1B Through the GSK3beta/TCF7 Pathway.

Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.

MACF1 promotes osteoblast differentiation by sequestering repressors in cytoplasm

Deficiency of Macf1 in Osterix Expressing Cells Decreases Bone Formation by Bmp2/Smad/Runx2 Pathway

Single-cell Multi-Omics Identify Novel Regulators Required for Osteoclastogenesis During Ageing

The age-related characteristics in bone microarchitecture, osteoclast distribution pattern, functional and transcriptomic alterations of BMSCs in mice

MACF1 Promotes Preosteoblast Migration by Mediating Focal Adhesion Turnover Through EB1.

Microtubule Actin Crosslinking Factor 1 Promotes Osteoblast Differentiation by Promoting Β‐catenin/tcf1/runx2 Signaling Axis

Constitutively activated AMPKα1 protects against skeletal aging in mice by promoting bone‐derived IGF‐1 secretion

Lipoteichoic acid restrains macrophage senescence via β-catenin/FOXO1/REDD1 pathway in age-related osteoporosis

Metformin acts on miR-181a-5p/PAI-1 axis in stem cells providing new strategies for improving age-related osteogenic differentiation decline

Single-cell multi-omics identify novel regulators required for osteoclastogenesis during aging

FOXO1 differentially regulates bone formation in young and aged mice

Knockdown of MACF1 Inhibits the Migration and Cytoskeletal Arrangement of Pre-Osteoclasts Induced by Simulated Microgravity

Knockdown of Microtubule Actin Crosslinking Factor 1 Inhibits Cell Proliferation in Mc3t3-E1 Osteoblastic Cells